There are no significant Insider Shareholders in Enliven Therapeutics as of December 12, 2025.
| Holder | Position | Shares | Report Date |
|---|---|---|---|
| Rishi Gupta | 7,663,349 | 20 May, 2024 | |
| Advisors Llc Orbimed | 7,663,349 | 20 May, 2024 | |
| David P Bonita | 1,049,767 | 23 Jul, 2021 | |
| Enterprise Associates 14, L.P. New | 652,763 | 07 Apr, 2022 | |
| Mark Chin | 586,018 | 27 Jul, 2021 | |
| Capital Management, L.P. Ra | 530,616 | 27 Feb, 2023 | |
| Braden Michael Leonard | 499,444 | 30 Dec, 2022 | |
| Capital Lp Commodore | 362,160 | 27 Feb, 2023 | |
| Andrew J. Schwab | 240,096 | 27 Feb, 2023 | |
| Joseph P Lyssikatos | Chief Scientific Officer | 902,688 | 31 May, 2024 |
| Samuel Kintz | President And CEO | 890,392 | 30 May, 2024 |
| Partners Vi, Llc 5Am | 635,341 | 16 Feb, 2024 | |
| Anish Patel | Chief Operating Officer | 263,311 | 10 Jan, 2025 |
| David M Mott | 57,306 | 23 Feb, 2022 | |
| Richard A. Heyman | 150,838 | 22 Oct, 2024 | |
| Jake Bauer | 21,843 | 27 Feb, 2023 | |
| Kenneth Attie | SVP And Cmo | 8,525 | 01 Feb, 2022 |
| Michael Gray | CFO & COO | 6,903 | 22 Feb, 2023 |
| Benjamin Hohl | Chief Financial Officer | 23,000 | 01 Oct, 2025 |
| Rahul D. Ballal | 22,341 | 10 Oct, 2024 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 08 Dec, 2025 | Anish Patel | Common Stock | D | 4,958 | $20.76 | 265,016 | I | S |
| 08 Dec, 2025 | Anish Patel | Common Stock | D | 1,705 | $21.78 | 263,311 | I | S |
| 19 Nov, 2025 | Joseph P Lyssikatos | Common Stock | D | 12,008 | $22.30 | 903,180 | I | S |
| 19 Nov, 2025 | Joseph P Lyssikatos | Common Stock | D | 492 | $23.09 | 902,688 | I | S |
| 17 Nov, 2025 | Samuel Kintz | Common Stock | D | 12,500 | $21.82 | 890,392 | I | S |
| 07 Nov, 2025 | Anish Patel | Common Stock | D | 6,054 | $17.35 | 270,587 | I | S |
| 07 Nov, 2025 | Anish Patel | Common Stock | D | 613 | $17.94 | 269,974 | I | S |
| 20 Oct, 2025 | Joseph P Lyssikatos | Common Stock | D | 12,500 | $22.08 | 915,188 | I | S |
| 17 Oct, 2025 | Samuel Kintz | Common Stock | D | 12,500 | $21.33 | 902,892 | I | S |
| 07 Oct, 2025 | Anish Patel | Common Stock | D | 6,667 | $20.10 | 276,641 | I | S |
| 29 Sep, 2025 | Benjamin Hohl | Common Stock | A | 3,250 | $2.48 | 26,250 | D | M |
| 29 Sep, 2025 | Benjamin Hohl | Common Stock | D | 3,250 | $20.40 | 23,000 | D | S |
| 26 Sep, 2025 | Joseph P Lyssikatos | Common Stock | D | 4,000 | $20.25 | 927,688 | I | S |
| 26 Sep, 2025 | Samuel Kintz | Common Stock | D | 3,700 | $20.06 | 915,392 | I | S |
| 23 Sep, 2025 | Joseph P Lyssikatos | Common Stock | D | 1,500 | $20.03 | 931,688 | I | S |
| 23 Sep, 2025 | Samuel Kintz | Common Stock | D | 2,800 | $20.03 | 919,092 | I | S |
| 19 Sep, 2025 | Joseph P Lyssikatos | Common Stock | D | 4,870 | $19.11 | 935,318 | I | S |
| 19 Sep, 2025 | Joseph P Lyssikatos | Common Stock | D | 2,130 | $20.02 | 933,188 | I | S |
| 17 Sep, 2025 | Samuel Kintz | Common Stock | D | 5,000 | $19.09 | 922,892 | I | S |
| 19 Sep, 2025 | Samuel Kintz | Common Stock | D | 1,000 | $20.25 | 921,892 | I | S |